Tech Company Financing Transactions
Arkeon Biotechnologies Funding Round
Arkeon Biotechnologies secured a $3 million funding round on 1/19/2023. Investors included ICL Planet Startup Hub.
Transaction Overview
Company Name
Announced On
1/19/2023
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
ICL Planet Startup Hub (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support its innovative and sustainable one-step fermentation bioprocess, which creates completely customizable protein ingredients by capturing the greenhouse gas carbon dioxide (CO2) and converting it into the 20 proteinogenic amino acids necessary for human nutrition.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Technopark 1
Tulln, 3430
Austria
Tulln, 3430
Austria
Phone
Undisclosed
Website
Email Address
Overview
Arkeon was founded to serve people and the planet through our revolutionary technology. We believe the way we live our lives should regenerate the world. And we're proud to have found a way to nourish people and revitalize our ecosystems at the same time. Our alternative protein ingredients are made with the help of carbon dioxide -- without relying on land, animals, or lots of water.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregor Tegl
Chief Technical Officer
Günther Bochmann
Co-Founder
Simon Rittmann
Browse more venture capital transactions:
Prev: 1/19/2023: iLife venture capital transaction
Next: 1/19/2023: Terminal49 venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs